Monashee Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,000
Closed -$15.6M 75
2025
Q2
$15.6M Buy
+20,000
New +$15.5M 5.65% 3
2017
Q3
Sell
-50,000
Closed -$4.12M 106
2017
Q2
$4.12M Buy
+50,000
New +$4.08M 1.74% 21

Other funds holding LLY

Monashee Investment Management's LLY Position: Q3 2025 in Review

Monashee Investment Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 20,000 shares — an estimated $15.6M sold.

Monashee Investment Management first reported a position in LLY in Q2 2017 and held it in 2 quarters. The position peaked at $15.6M in Q2 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Monashee Investment Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Monashee Investment Management sold 20,000 Eli Lilly shares in Q3 2025, an estimated $15.6M.
  • Monashee Investment Management first reported a position in Eli Lilly in Q2 2017 and held it in 2 quarters.
  • Monashee Investment Management's Eli Lilly position peaked at $15.6M in Q2 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Monashee Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.